Lp(a) false laboratory values

 From European Atherosclerosis Society Consensus Statement

Eur Heart J 2022;43:3925-46.

(Click on the image to enlarge)

Apixaban - for post-cardiac surgery children

Apixaban

(Eliquiss®)

General principles of use in children (post-cardiac surgery)

Dose is weight-based.

For an adult size person, 5 mg BID may be used.

Under some circumstances 7.5 mg BID may be used.

Dose is adjusted for renal and hepatic dysfunction.

Monitoring: 

Check peak level, about 3-4 hrs after morning dose, after 4 doses.

For post-cardiac surgery children, Anti-Xa (Apixaban-specific) level is kept at 100-300 ng/ml.

For a 3-mo course (short course), repeat peak level once about 2-3 weeks later.

After that, repeat peak level is done if the dose is changed or bleeding occurs.